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Abstract 
Roughly every 42 seconds an American experiences a myocardial infarction (MI). More 
importantly, over a third will have another MI within 6 years. Approximately 34% of deaths 
from heart disease could have been delayed or prevented through changes in health habits such 
as sleep. Examining sleep in those post MI is important to understanding the associations 
between sleep and cardiovascular health. The purpose of this senior honors project was to 
examine the associations between sleep duration and sleep quality and the reoccurrence of MI in 
adults. A secondary analysis of data from a comparative research study (N=156) that examined 
MI reoccurrence in Blacks and Whites was used to investigate the relationships between sleep 
duration, sleep quality, and MI reoccurrence via Pearson’s correlation, chi-square, and t-test. 
Short and long sleep durations were not significantly associated with MI reoccurrence (χ2 = 
3.603 (3), p = 0.31).  However, there was a significant difference in sleep efficiency (χ2 = 11.16 
[3], p =  0.01) and overall sleep quality and MI reoccurrence (χ2 = 14.88 [1], p < 0.001). 
Together, these findings suggest that sleep quality and efficiency may have a stronger influence 
on cardiovascular health than sleep duration alone.  
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Sleep and Myocardial Infarction Reoccurrence 
The rapid rise in the prevalence of heart disease in America has become one of the major 
challenges facing the global healthcare delivery system. Cardiovascular disease (CVD) accounts 
for 1 out of every 4 deaths in the United States, killing over 800,000 people in in 2016. More 
importantly, 34% of the deaths attributed to CVD could have potentially been prevented or 
delayed through changes in health habits such as sleep (Centers for Disease Control and 
Prevention [CDC], 2016). Following a healthy lifestyle can help individuals prevent and reduce 
CVD risk. One of the most common types of CVD and a novel indicator of health risk is 
coronary heart disease (CHD). Every 42 seconds, a person suffers a heart attack in the United 
States (CDC, 2016). Survivors of first time myocardial infarctions (MI) face a considerable risk 
of future cardiovascular events, including ischemic strokes, recurrent MIs, heart failure, and 
death (Wilson, Douglas, Alpert, Simons & Breall, 2017). The World Health Organization (2016) 
reports that compared to those without an MI, those who have experienced an MI have a higher 
death rate. In fact, when comparing these two groups by age, those who have had an MI are 6 
times more likely to die than those in the same age group who have not experienced an MI. Thus, 
focusing on individuals post MI is essential to reducing mortality risk. 
Sleep duration has been identified as a risk factor for cardio-metabolic disease and 
mortality as adverse outcomes and comorbidities have been associated with both short and long 
sleep duration (Léger, Beck, Richard, Sauvet & Faraut, 2014; Torre-Bouscoulet et al., 2013). 
Existing literature examining sleep duration as a risk factor for CHD has shown inconsistent 
associations. Collective comparisons on sleep duration studies are difficult because of the 
varying categories of sleep durations and research methodologies. Research concerning the 
modifiable and non-modifiable factors, including sleep, and CHD are necessary to understand 
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the relationship between sleep and MIs. Examining the influence and relationship that sleep has 
on the body may help clinicians reduce acute MI reoccurrences and deaths in the future. Studies 
of sleep duration and secondary MI risk are extremely limited. Large scale studies have 
demonstrated varying relationships and findings concerning sleep and MI (Cappuccio et. al, 
2010; Kronholm, Laatikainen, Peltonen, Sippola & Partonen, 2011). A prompting the need for 
additional research. 
This project aims to address the cardiovascular focus of the Healthy People 2020 
guideline by “improving cardiovascular health and quality of life through prevention, detection, 
and treatment of risk factors for heart attack; prevention of repeat cardiovascular events; and 
reduction in deaths from CVD” (Office of Disease Prevention and Health Promotion [ODPHP], 
2017, para. 1). Currently, sleep is not widely considered to be a modifiable risk factor for 
developing heart disease. However, examining the associations of sleep on MI reoccurrence may 
yield information on relationships or perhaps confirm previous findings on the influences of 
sleep on cardiovascular risk. Such research may impact health policies in the future. 
Preventing CHD can also decrease its associated health care costs. The central and 
eastern North Carolina regions have the highest death rates attributed to MIs in the state, costing 
the state healthcare system an estimated $2 billion annually. Further research and analysis are 
necessary to better understand the variables associated with MI reoccurrence to develop 
guidelines that include various factors of healthy living and emphasize the importance of healthy 
sleeping habits and mental health. The priority health need for NC residents is to prevent the 
progression and prevalence of CHD. 
 
 
Running head: SLEEP AND MYOCARDIAL INFARCTION REOCCURRENCE  5 
Literature Review 
An electronic-based search was conducted using Ovid, PubMed, MEDLINE, Cumulative 
Index to Nursing and Allied Health (CINAHL), and the Cochrane Library databases for original 
research articles published in English from 2005-2016. Medical subject headings (MeSH) terms 
were used when available and appropriate. Various terms such as “sleep duration,” “myocardial 
infarction,” “cardiovascular disease,” “PSQI,” “coronary heart disease,” “recurrent myocardial 
infarction,” and “subjective sleep” were searched using a boolean technique to limit relevant 
study designs and subjects for inclusion in the review. The article titles and abstracts were 
reviewed for significance, and pertinent full-text studies were extracted for review and synthesis. 
Subjective Measurement of Sleep 
One of the most widely used subjective measures of sleep includes the Pittsburgh Sleep 
Quality Index (PSQI) measurement tool. Researchers at the University of Pittsburgh Medical 
Center developed the PSQI in 1989 as an instrument specifically designed to measure subjective 
sleep quality in clinical populations for application in future psychiatric practices and research. 
The PSQI is a self-rated questionnaire that assesses sleep quality and disturbances over a 1-
month period. Nineteen individual items measured on a scale of 0-3 generate seven “component” 
scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleeping medication, and daytime dysfunction. The sum of the scores for 
these seven components yield one global score which has a range of 0 to 21 with higher scores 
indicating worse sleep quality. 
Two studies measuring the application of the PSQI found strong positive evidence for 
reliability and validity in a variety of non-clinical and clinical adult samples. A global PSQI 
score >5 yielded a diagnostic sensitivity of 89.6% and specificity of 86.5% (kappa = 0.75, p 
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<0.001) in distinguishing good and poor sleepers (Buysse et al., 1989). A meta-analysis of 37 
studies examined the PSQI as a screening tool for sleep dysfunction in clinical and non-clinical 
adult samples. These studies analyzed the construct/group validity, internal consistency, and test-
retest reliability of the PSQI measurement. The PSQI showed measures of strong reliability and 
validity, and moderate structural validity in a variety of samples, suggesting that the PSQI tool 
fulfills its intended utility in sleep quality measurement (Mollayeva et al., 2015). Despite the 
number of studies reporting subjective measurements as a limitation to research, (Cappuccio, 
Cooper, D’Elia, Strazzullo & Miller, 2011; Léger et al., 2014; Torre-Bouscoulet et al., 2013) 
studies concerning the use of subjective sleep measurements found that although sleep duration 
is often over-reported, subjective sleep quality is strongly correlated with polysomnographic and 
other objective sleep measurements (Lauderdale, Knutson, Yan, Liu, & Rathouz 2008; 
Mollayeva et al., 2015). 
Demographics 
There is a clear trend of reduced sleep duration emerging in the general population of 
western countries like the United States. The proportion of adults who sleep less than six hours 
per night in the United States is now greater than at any other time period (Jones, 2013). A cross-
sectional population based study investigating sleep patterns for a nationally representative 
sample of 110,441 American adults, noted that 1 in 3 Americans were either sleeping too much 
(> 9 hours) or not getting enough sleep (< 6 hours). The findings of this study (Krueger & 
Friedman, 2009) suggest that numerous demographic, familial, socioeconomic, and health 
behavior factors may shape sleep duration; emphasizing the need for further research that adjusts 
for such factors when analyzing the relationship between sleep and other health or mortality 
outcomes  
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There are difference in sleep duration by race.  Krueger and Friedman found that older 
individuals were more likely to report either short or long sleep when compared with younger 
individuals (2009). Compared with Caucasians, Hispanics are more likely to report short sleep 
(Hale & Do, 2007), and African American’s are more likely to report both short and long sleep 
(Hale & Do, 2007; Krueger & Friedman, 2009). Reporting short or long sleep is also associated 
with low socioeconomic status (Cappuccio et al., 2011; Krueger & Friedman, 2009; Patel et al., 
2009), and those working long hours (Krueger & Friedman, 2009).  
Studies have found varying associations of sleep duration and CHD after factoring for 
covariates such as socioeconomic status, health, gender, and age (Lauderdale et al., 2008; Marie-
Pierre, 2016; Torre-Bouscoulet et al., 2013).  One large international systematic review of 15 
studies and 24 cohorts totaling nearly half a million people yielded evidence of the relationships 
between duration of sleep and morbidity/mortality from CHD, stroke, and total CVD (Cappuccio 
et al., 2011). In contrast to individual studies (Meisinger, Heier, Löwel, Schneider, & Döring 
2007; Léger at al., 2014; Kronholm et. al, 2011), this meta-analysis found no gender differences 
associated with short or long duration of sleep and cardiovascular outcomes. In summary, 
differences in age, race, social economic status, and work hours, but not sex, have consistently 
been associated with sleep duration and negative cardiovascular outcomes. Therefore, it is 
important to examine these variables when studying sleep and MIs. 
Sleep Duration and Myocardial Infarction 
Short sleep duration imposed on healthy individuals increases sympathetic activity in the 
nervous system and elevates blood pressure. Thus, altered sleep duration could potentially lead 
to adverse cardiovascular sympathetic consequences and death. Recent reviews find that sleep 
duration is associated with mortality in a U-shaped fashion (Grandner, Hale, Moore & Patel 
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2010; Cappuccio et al., 2011; Gallicchio, 2009). However, a review conducted by Kurina and 
colleagues (2013) suggested that the consensus on these associations is unclear. The conclusions 
of this study stress that careful attention should be paid to measurement bias, reverse causation, 
and confounding factors when interpreting associations between sleep duration and mortality. 
Gallicchio & Kalesan conducted a meta-analysis of 23 international studies including 
men and women from 1979 to 2007 exploring the association between sleep duration and 
mortality. Using a random effects meta-analysis, the authors reported the pooled relative risk 
(RR) of all-cause mortality for short sleep (< 7 hours) as 1.10 (95% confidence interval [CI] 
1.06-1.15) and a cardiovascular-related RR of 1.06 (95% CI 0.94-1.30). While short sleep carries 
an increased risk for mortality, this association is not totally explained by CVD. Long duration of 
sleep (> 8 hours) significantly increased the risk for all-cause, cancer and cardiovascular 
mortality (2009). 
A meta-analysis of 16 published studies from 1993 to 2009, including 1,382,999 male 
and female participants, and 112,566 confirmed deaths, found a relationship between all-cause 
mortality and sleep duration. The relative risk for sleep duration and mortality produced similar 
results of previous studies: RR of 1.12 (95% CI 1.06-1.18) for short sleep and RR of 1.30 (95% 
CI 1.22-1.38) for long sleep. A secondary meta-analysis by Cappuccio et al., (2011) reviewed an 
additional 15 studies from 1966 to 2009 including 474,684 male and female participants. 
Investigators found that short sleep durations (≤ 5-6 hours) were associated with a RR of 1.48 
(95% CI 1.22-1.80) while long sleep durations (> 8-9 hours) were associated with a RR of 1.38 
(95% CI 1.15-1.66) of developing CHD or dying. 
The relationship between sleep duration and CVD mortality risk is also supported by a 
Finnish study of 25,000 participants that found the highest risk of CVD mortality exists for those 
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on the extreme ends of sleep duration distribution (Kronholm et al., 2011). A review paper from 
Grandner and colleagues (2010) confirmed that “there is strong evidence for sleep duration, both 
short and long, as a risk factor for CVD, even though the mechanisms are not understood” (p. 
95).  More recently, a cross-sectional study examining sleep duration in 30,000 American adults 
showed that the shortest (< 5 hours) and longest (> 10 hours) durations of sleep were associated 
with the highest odds for MI occurrence. Short sleep in particular, indicated significant predictor 
for the occurrence of MI (B= 2.513; p < 0.01) (Altman et.al, 2012). There were no relevant 
studies that examined sleep and cardiovascular risk for MI recurrence. 
Collectively, these studies clearly suggest that sleep duration is associated with mortality 
and cardiovascular outcomes. Specifically, both short and long sleep duration are associated with 
elevated risk. While much of the recent literature has focused on the relationship of sleep 
duration, mortality, and first occurrence cardiovascular morbidities, less is known about the 
relationships of sleep duration and secondary CVD events such as MI and stroke; highlighting 
the continuous need for improved risk prediction and correlation for secondary prevention. 
Sleep Quality and Myocardial Infarction  
 Impairments in sleep quality, changes in sleep duration, and sleep disorders are one of the 
major complaints following an acute MI and evidence indicates that components of sleep, other 
than sleep duration, are important to investigate in post MI patients (Cappuccio et. al, 2010; 
Grandner et. al, 2010; Altman et. al, 2012). A 2015 study investigating sleep quality and adverse 
outcomes (death, recurrent MIs, and stroke) in 113 patients with acute MIs, found that poor sleep 
quality was frequent in hospitalized patients with MIs and negatively affected the recovery 
process. The final PSQI score was the only variable independently associated with worsening of 
clinical outcomes. The PSQI scores were significantly higher in those whose clinical progression 
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had worsened after an MI compared to those who improved (p < 0.005), indicating that worse 
sleep quality is associated with negative cardiovascular outcomes. Sleep efficiency, as assessed 
through the PSQI was significantly different between those with worsening clinical conditions 
and improved or stable clinical conditions, 62.5% and 81.2% respectively (p < 0.005) 
(Andrechuk & Ceolim, 2015). Similarly, a Japanese study using a population based survey of 
3,403 participants discovered a significant positive association between the PSQI global score 
and MI occurrence (p < 0.05) as well as the number of existing comorbidities (p < 0.0001). As 
the number of comorbidities rise, the PSQI scores also increased in a linear fashion (Hayashino 
et. al, 2010). These studies highlight and support the complex relationship between sleep quality 
and cardiovascular health.  
Purpose 
The purpose of this senior honors project was to examine the relationship between sleep, 
and the reoccurrence of MI in adults who have experienced one or more MIs in the last 3-7 
years.  The application of this study is intended to address the increasing health concern of CVD, 
and more specifically, CHD by studying the relationships between sleep duration, sleep quality, 
and recurrent MIs. The ultimate goal of this study was to understand how sleep is associated with 
MI reoccurrence. 
Research Question 
Is there a difference in sleep duration and sleep quality in adults who have had one MI 
compared to those who have had more than one MI? 
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Methodology 
Design  
This investigation consisted of a cross-sectional secondary analysis utilizing data from a 
comparative research study that analyzed differences between Blacks and Whites in MI 
reoccurrences. The relationships between sleep and MI reoccurrence were investigated via 
Pearson’s correlation, chi-square, and t-test. The data were described using descriptive statistics 
(means, standard deviations, percentiles) to better understand the sample population. Sleep 
durations were categorized into short (≤ 7 hours), adequate (7-9 hours), and long (≥ 9 hours). 
Total PSQI scores were dichotomized into 2 groups: scores ≤ 4 indicating good sleep quality and 
scores > 4 indicating poor sleep quality. All data were analyzed using the statistical package for 
social science (SPSS v.22). Statistical significance was accepted as p ≤ 0.05. 
Sample 
The sample was comprised of English speaking male and female adults aged 25 and older 
who experienced an MI within last 3-7 years. White and Black subjects were recruited as a 
convenience sample from two medical centers in North Carolina. Blacks were over sampled to 
reflect the racial prevalence of MIs in the region. Exclusion criteria included the presence of 
memory deficit as identified by the Abbreviated Mental Test, taking antidepressants for less than 
3 months, and major surgery within the last 6 months. 
Data Collection 
For this secondary analysis, the data included descriptive data, the PSQI seven individual 
components of sleep, total PSQI score, and number of MIs, one or more than one.  Participants in 
the study completed a self-reported Demographic Health Form, while sleep duration and quality 
were assessed with the PSQI tool − a subjective sleep questionnaire. 
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Results 
Demographics  
The convenience sample (N=156) consisted of 89 men and 67 women who experienced a 
MI. The mean age of participants was 65.4 years old (SD = 12.1). Most of the sample were men 
(57%), married (62%), and White (68%).  Half (51%) had a high school education or less, and 
65% had a history of only one MI. Baseline characteristics are summarized in Table 1. Self-
reports of sleep duration per night ranged from 2 to 10 hours (See Figure 1). Participants 
averaged about 6 hours and 35 minutes (SD = 1.68) of sleep per night, with 75% of individuals 
reporting ≥ 8 hours of sleep per night, while 50% reported sleeping at least 7 hours. The mean 
PSQI total score was 6.97 (SD = 3.87; Range 2-7), and 63% reported poor sleep quality (PSQI 
total score > 4).  
Sleep Quality 
There was a significant difference in sleep efficiency (χ2 = 11.16 [3], p =  0.01) and 
overall sleep quality and MI reoccurrence (χ2 = 14.88 [1], p < 0.001). There was a significant 
difference (p < 0.01) in total PSQI scores with those having a recurrent MI having significantly 
higher mean scores (t = -2.775). 
Sleep Duration 
When sleep duration was compared directly with MI reoccurrence, there was no 
significant difference in sleep duration (>7, 6-7, 5-6, or <5 hours) and MI reoccurrence (> 1 MI) 
χ2 = 3.603 (3), p = 0.31. 
Discussion 
Contrary to the literature, this study did not support a predictive U-shaped relationship 
between self-reported sleep duration and MI reoccurrence. Sleep durations for short and long 
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sleep were not associated with recurrent MIs. Participants who had only one MI reported better 
sleep efficiency scores than those who experienced a recurrent MI. Overall, poorer sleep quality 
was associated with those who had a recurrent MI.  
Findings of this study are consistent with previous studies investigating poor sleep quality 
and acute MIs. The evidence echoes a significant difference in total PSQI scores and sleep 
efficiency between patients who improved following an MI and those whose clinical conditions 
worsened (Andrechuk & Ceolim, 2015; Hayashino et. al, 2010). Alterations in sleep following 
an MI are prevalent. The results of this secondary analysis demonstrate the importance of 
examining the associations between sleep quality and MI occurrence to minimize cardiovascular 
risk through interventions designed to improve sleep quality and manage sleep disorders, 
particularly in those post MI. Results of this study suggest that sleep duration may play lesser of 
a role than the efficiency and quality of sleep. Individuals with poor sleep quality who sleep the 
recommended 7-8 hours of sleep per night may still be at an increased risk for further MIs. Thus, 
short and long sleepers may be protected from cardiovascular mortality with good quality sleep. 
Further study is warranted to understand sleep efficiency and CHD risk. 
One of the best ways to reduce future cardiovascular mortality risk in those post-MI is to 
strengthen the myocardium through physical activity. Inadequate sleep and poor sleep quality 
often precedes fatigue, one of the prevailing causes of a lack of exercise in post-myocardial 
infarction populations (Alsén & Brink, 2013; Crane, Abel, & McCoy, 2014). Fatigue presents a 
significant barrier to cardiovascular rehabilitation by decreasing an individual’s ability to engage 
in physical activity. Therefore, sleep is especially important in this population who have a 
heightened need for increased physical activity to strengthen the heart muscle and reduce future 
mortality risk. Because exercise is an important aspect in preventing or delaying recurrent MIs 
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and is often influenced by a person’s level of fatigue, examining sleep and MI reoccurrence is 
important as a prerequisite to understanding the pathophysiology behind fatigue and CHD. 
Understanding these associations may help clinicians develop effective interventions for MI 
patients in the future. 
Limitations of this study include the convenience sampling and cross sectional design of 
this study. Sleep duration and quality were assessed through a subjective questionnaire, may not 
reflect true sleep duration numbers. Various factors were not included in the analysis that may 
have influenced sleep, such as medications, sleep apnea, and age. 
Inconsistent categorizations of sleep duration in the literature make it difficult to 
standardize sleep duration. There is limited research that exists on the influence of sleep on the 
incidence of MIs, particularly studies of sleep and MI reoccurrence. Future research studies 
should focus on the associations between sleep and both primary/secondary MI occurrences 
while accounting for various factors such as inflammatory marker levels, medications, physical 
activity levels, and fatigue. 
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Table 1 
Demographic Statistics by MI Occurrence 
 
Variable           1 MI   n (%)*         > 1 MI   n (%)* 
Age 
 
Gender 
Male 53 (52) 36 (67) 
Female 49 (48) 18 (33) 
 
Marital Status 
Single & Never Married                        8 (8) 10 (19) 
Married 67 (66) 29 (54) 
Divorced/Separated 15 (15) 12 (22) 
Widowed 12 (12) 3 (6) 
 
Education 
< High School        19 (19) 13 (24) 
High School Graduate/GED       28 (27) 19 (35) 
Some College/Technical School       27 (27) 11 (20) 
Graduate of College/Technical School       28 (28) 11 (20) 
 
Body Mass Index  
Under       < 19 1 (1) 2 (6) 
Ideal         19-24.9 19 (20)   7 (20) 
Over         25-29.9 30 (29) 16 (30) 
Obese       > 30 52 (51) 34 (44) 
 
Ethnicity/Race 
African American / Black 31 (30) 15 (28) 
Caucasian / White 69 (68) 37 (69) 
Other 2 (2) 2 (4) 
 
Combined Yearly Household Income 
< $30,000 43 (42) 30 (56) 
$30,000-$80,000 40 (39) 17 (31) 
> $80,000 9 (9) 4 (7) 
Unknown 10 (10) 3 (6) 
* rounded percentages 
<60 30 (30) 17 (32) 
60-70 37 (36) 17 (32) 
70+ 35 (34) 20 (36) 
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Figure 1 
 
 
 
 
 
 
 
